Linfoma cutáneo asociado a metotrexato en un paciente con artritis reumatoide

Vanesa Antón Vázquez; Héctor Corominas; Nadia García Muñoz; Gisela Hebe Petiti

doi:10.7399/fh.10898

Linfoma cutáneo asociado a metotrexato en un paciente con artritis reumatoide

Vanesa Antón Vázquez, Héctor Corominas, Nadia García Muñoz, Gisela Hebe Petiti

Resumen

Palabras clave

Texto completo:

PDF

Referencias

Ekstorm K, Hjalgrim H, Brandt L, Baecklund E, Klareskog L, Ekbom A. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first degree relatives. Arthritis Rheum. 2003;48:963-70.

Georgescu L, Quinn GC, Schwartzman S, Paget SA. Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment. Semin Arthritis Rheum. 1997;26:794-804.

Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood. 2002;99:3909-15.

Feng W-H, Cohen JI, Fischer S, Li L, Sneller M, Goldbach-Mansky R, et al. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. J Natl Cancer Inst. 2004;96:1691-702.

Tournadre A, D’Incan M, Dubost JJ, Franck F, Dechelotte P, Souteyrand P, et al. Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients treated with methotrexate. Mayo Clin Proc. 2001;76:845-8.

Tosato G, Steinberg AD, Blaese RM. Defective EBV-specific suppressor T-cell function in rheumatoid arthritis. N Engl J Med. 1981;305:1238-43.

Maruani A, Wierzbicka E, Machet MC. Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after with- drawal of methotrexate therapy for rheumatoid arthritis. J Am Acad Dermatol. 2007;57:69-71.

Viraben R, Brousse P, Lamant L. Reversible cutaneous lymphoma occurring during methotrexate therapy. Br J Dermatol. 1996;135:116-8.

Baird RD, van Zyl-Smit RN, Dilke T, Scott SE, Rassam SMB. Spontaneous remission of low-grade B-cell non-Hodgkin’s lymphoma following withdrawal of methotrexate in a patient with rheumatoid arthritis: case report and review of the literature. Br J Haematol. 2002;118:567-8.

Yamada K, Oshiro Y, Okamura S, Fujisaki T. Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders. Histopathology, 2015. 67(1):70-80. DOI: 10.1111/his.12627

DOI: http://dx.doi.org/10.7399%2Ffh.10898